Mesa Laboratories Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +56.3% | -54.2% | +220.2% | +23.1% | -13.1% | +39.6% | +5.8% | -28.7% | +57.7% | +6.1% | -8.5% | |
| – | +26.8% | +21.8% | +8.4% | -0.5% | +37.8% | +36.0% | +41.9% | +34.9% | -6.7% | -22.3% | -5.1% | |
| – | +33.6% | +6.3% | +18.5% | +151.9% | +31.2% | +67.7% | +22.9% | +10.1% | -4.8% | +10.1% | +36.0% | |
| – | -215.7% | – | – | -57.9% | +19.6% | +63.7% | +72.0% | -46.9% | – | – | – | |
| – | – | – | – | +143.5% | -139.8% | – | -236.9% | – | – | +15.6% | -172.2% | |
| – | +173.3% | +50.1% | -75.9% | -54.9% | +18.7% | +33.0% | +122.5% | +2.5% | -43.5% | +75.3% | -27.8% | |
| – | +36.2% | -42.2% | -6.6% | -77.4% | +4,683.1% | -98.9% | +15,222.5% | -96.9% | +756.4% | -94.5% | -27.8% | |
| – | +5.5% | +2.3% | +2.5% | +2.0% | +10.6% | +16.3% | +5.5% | +2.0% | +1.2% | +0.6% | +1.6% | |
| – | +27.9% | +82.7% | -16.9% | -274.5% | – | -15.3% | -100.6% | – | -110.4% | – | – | |
| – | +94.9% | -49.7% | -190.3% | +173.9% | – | -100.5% | – | -173.5% | – | -212.9% | -36.8% | |
| – | +105.2% | -42.5% | -175.8% | +166.9% | – | -36.8% | -64.0% | -163.4% | – | -235.5% | -6.0% | |
| – | – | -96.6% | -380.8% | – | +1,409.6% | +156.3% | -217.6% | – | – | – | – | |
| – | +14.8% | -142.0% | – | +33.1% | -14.4% | +40.0% | -0.8% | -32.6% | +77.3% | +1.8% | -6.4% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.